Menlo Park, CA
BillionToOne, Inc. operates as a diagnostics company. The Company detects genetic disorders in the developing baby from maternal blood, as well as invents the patent-pending molecular counter platform, which increases the resolution of cell-free DNA detection by over a thousandfold. BillionToOne serves customers in the United States.
billiontoone.comThese are collections BillionToOne is a part of. Click on the collection name to view similar companies.
Series D
$130,000,000
Series C
$48,500,000
Debt Financing
$35,000,000
Series C
$125,000,000
Series B
$55,000,000
Series A
$15,000,000
Series A
$15,000,000
Seed
$2,400,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on BillionToOne.